Mien-Chie Hung Selected Research

RNA (Ribonucleic Acid)

1/2023	Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics.
1/2021	Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.
1/2021	NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation.
3/2019	Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma.
1/2018	Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer.
10/2012	LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
9/2011	Mesenchymal stem cells promote formation of colorectal tumors in mice.
10/2010	Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
2/2002	Expression profile of tyrosine kinases in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mien-Chie Hung Research Topics

Disease

322	Neoplasms (Cancer) 03/2024 - 01/2002
141	Breast Neoplasms (Breast Cancer) 03/2024 - 02/2002
67	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2002
42	Carcinogenesis 01/2021 - 06/2002
31	Triple Negative Breast Neoplasms 09/2023 - 09/2009
20	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 11/2002
17	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 03/2002
14	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2004
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2011
13	Adenocarcinoma 01/2022 - 06/2007
13	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2003
13	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 03/2003
12	Infections 11/2023 - 10/2002
12	COVID-19 11/2023 - 01/2020
11	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2002
9	Hypoxia (Hypoxemia) 01/2021 - 04/2005
7	Esophageal Neoplasms (Esophageal Cancer) 12/2015 - 06/2007
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2002
6	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 02/2009
6	Colonic Neoplasms (Colon Cancer) 01/2018 - 10/2002
5	Inflammation (Inflammations) 01/2023 - 08/2007
4	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2015
4	Disease Progression 01/2024 - 05/2006
4	Bites and Stings (Sting) 01/2023 - 01/2022
4	Obesity 01/2023 - 11/2008

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2002
44	Phosphotransferases (Kinase)IBA 04/2024 - 02/2002
30	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2002
22	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2017
22	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2004
21	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2002
19	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2009
18	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2024 - 11/2004
17	LigandsIBA 03/2024 - 08/2002
16	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2002
15	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 02/2016
15	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2010
14	Trastuzumab (Herceptin)FDA Link 07/2014 - 10/2002
12	B7-H1 AntigenIBA 05/2023 - 10/2017
12	Monoclonal AntibodiesIBA 10/2022 - 10/2002
11	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 02/2002
11	Epidermal Growth Factor (EGF)IBA 12/2018 - 11/2006
11	Liposomes (Liposome)IBA 01/2015 - 11/2002
10	Long Noncoding RNAIBA 01/2023 - 11/2014
10	Cadherins (E-Cadherin)IBA 01/2022 - 06/2005
10	Hormones (Hormone)IBA 01/2021 - 01/2004
10	Small Interfering RNA (siRNA)IBA 04/2018 - 05/2007
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 10/2002
9	Ribonucleases (Ribonuclease)IBA 02/2024 - 09/2012
9	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2002
9	CytokinesIBA 01/2021 - 11/2008
8	Estrogen ReceptorsIBA 01/2023 - 06/2009
8	Messenger RNA (mRNA)IBA 01/2023 - 10/2005
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2011
8	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 05/2008
8	LuciferasesIBA 11/2019 - 03/2004
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 10/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 08/2007
7	Immune Checkpoint ProteinsIBA 03/2024 - 01/2018
7	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2023 - 10/2003
7	AntibodiesIBA 05/2023 - 04/2004
7	Sirolimus (Rapamycin)FDA Link 01/2017 - 02/2004
7	Histones (Histone)IBA 08/2016 - 09/2008
7	NF-kappa B (NF-kB)IBA 04/2012 - 10/2002
7	beta CateninIBA 02/2009 - 10/2002
6	LipidsIBA 05/2024 - 07/2002
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2011
6	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 06/2014
6	Cetuximab (Erbitux)FDA Link 01/2022 - 12/2015
6	tyrosine receptor (receptor, tyrosine)IBA 06/2021 - 11/2009
6	human ERBB2 proteinIBA 01/2021 - 04/2013
6	Peptides (Polypeptides)IBA 01/2021 - 10/2002
5	Gemcitabine FDA Link 01/2024 - 10/2003
5	Therapeutic UsesIBA 01/2023 - 09/2004
5	EnzymesIBA 01/2023 - 06/2009
5	ChromatinIBA 01/2023 - 05/2007
5	Programmed Cell Death 1 ReceptorIBA 01/2022 - 12/2018
5	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2019
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 09/2010
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 11/2009
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 05/2012
5	TOR Serine-Threonine KinasesIBA 02/2010 - 10/2004
5	I-kappa B KinaseIBA 10/2009 - 04/2004
5	Glycogen Synthase Kinase 3 betaIBA 02/2009 - 06/2005
4	Angiotensin-Converting Enzyme 2IBA 11/2023 - 06/2021
4	InterferonsIBA 01/2023 - 10/2008
4	Chemokine ReceptorsIBA 01/2023 - 11/2004
4	AntigensIBA 10/2022 - 03/2011
4	ParaffinIBA 01/2022 - 08/2011
4	Protein Isoforms (Isoforms)IBA 01/2022 - 05/2007
4	Formaldehyde (Formol)FDA Link 01/2022 - 05/2010
4	Polysaccharides (Glycans)IBA 01/2022 - 08/2011
4	Arginine (L-Arginine)FDA Link 01/2021 - 09/2015
4	AndrogensIBA 01/2020 - 03/2005
4	Endoplasmic Reticulum Chaperone BiPIBA 01/2020 - 11/2014
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 02/2006

Therapy/Procedure

121	Therapeutics 03/2024 - 11/2002
32	Immunotherapy 03/2024 - 10/2017
31	Drug Therapy (Chemotherapy) 01/2024 - 10/2003
6	Radiotherapy 10/2022 - 09/2011